Human Gene Therapy, Mary Ann Liebert Inc.

Human Gene Therapy Named one of the 100 Most Influential Journals in Biology and Medicine over the last 100 Years, by the BioMedical and Life Sciences Division of the Special Libraries Association on the occasion of its Centennial. Official Journal of: The European Society of Gene and Cell Therapy (ESGCT) The British Society for Gene Therapy (BSGT) Société Francophone de Thérapie Cellulaire et Génique (SFTCG) The Irish Society for Gene & Cell Therapy (ISGCT) The Israeli Society of Gene & Cell Therapy (ISGCT) Deutsche Gesellschaft für Gentherapie e.V. (DG-GT) Sociedad Española de Terapia Génica y Celular (SETGYC) De Nederlandse Vereniging voor Gentherapie (NVGT) www.liebertpub.com/hum
Audience	Researchers and clinicians, including all members of the societies for which Human Gene Therapy is the official publication
Frequency	Monthly
Editorial Focus	The leading peer-reviewed journal for all aspects of human gene therapy. Publishes scientific papers on original investigations into the transfer and expression of genes in mammals, including humans. Improvements in vector development, delivery systems and animal models, particularly in the areas of cancer, AIDS, heart disease, genetic disease and neurological disease are covered. Ethical/legal/regulatory papers related directly to the area of gene transfer into humans and a continuously updated directory of human gene marker and gene therapy clinical protocols. Details of new clinical protocols in each issue.
Editor(s) in Chief	James M. Wilson, M.D., Ph.D. University of Pennsylvania School of Medicine, Gene Therapy Program Deputy Editor Bernd Gansbacher, M.D., Ph.D. Institut für Experimentelle Onkologie und Therapieforschung, Technische Universität München
Print Advertising Options	Adverts, Inserts & Supplements
Digital Advertising Options	Banners on website Banners on subscriber Table of Contents email alerts
Further Information	Hilary Turnbull Tel: +44 (0) 1875 825 700 hturnbull@impressmedia.com
Publisher	Human Gene Therapy is owned and published by Mary Ann Liebert, Inc. Editorial headquarters: 140 Huguenot Street, New Rochelle, New York 10801, USA. Phone: +1 (914) 740-2100. Fax: +1 (914) 740-2101 www.liebertpub.com

Human Gene Therapy

Named one of the 100 Most Influential Journals in Biology and Medicine over the last 100 Years, by the BioMedical and Life Sciences Division of the Special Libraries Association on the occasion of its Centennial.